Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT ID: NCT02839980
Last Updated: 2023-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
399 participants
OBSERVATIONAL
2016-10-06
2018-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02840656
Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital
NCT05798351
Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg
NCT04995965
Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus
NCT02547272
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
NCT01703299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
orthopedics (gr1) surgery
parient admitted to the orthopedics (gr1) surgery ward for an elective or semi-emergent surgical procedure.
No interventions assigned to this group
thoracic (gr2) surgery
parient admitted to the thoracic (gr2) surgery ward for an elective or semi-emergent surgical procedure.
No interventions assigned to this group
abdominal (gr3) surgery
parient admitted to the abdominal (gr3) surgery ward for an elective or semi-emergent surgical procedure.
No interventions assigned to this group
ICU (gr4)
patients admitted to the ICU with an antcipated length of stay of 3 days or more
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted in one of the participating surgery wards for elective or semi-emergent surgerical procedure or in one of the ICUs;
* for an anticipated length of stay of 72h
Exclusion Criteria
* bronchectasis;
* patient's or proxies' opposition to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan MESSIKA, MD,
Role: PRINCIPAL_INVESTIGATOR
Hopital Louis Mourier - Assistance Publique Hopitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AP-HP, Louis Mourier Hospital
Colombes, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NI15006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.